Kalmeda Tinnitus Study

Organizational Data

DRKS-ID:
DRKS00022973
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2020-10-09
Last update in DRKS:
2022-10-06
Registration type:
Retrospective

Acronym/abbreviation of the study

TKS

URL of the study

http://www.hno-praxis-duisburg.de/tinnitusstudie

Brief summary in lay language

The Kalmeda Tinnitus App offers cognitive behavioural therapy based on the Zurich Resource Model as well as acceptance and commitment therapy for patients with chronic tinnitus. The Kalmeda Tinnitus App is already approved as a medical device in Germany and has been available in the App and Playstore since the beginning of 2019. The Kalmeda Tinnitus Study aims to prove the improvement of the tinnitus burden and thus a positive supply effect by using the Kalmeda Tinnitus App. In addition, further effects of the use of the Kalmeda Tinnitus App on the self-efficacy, the stress experience as well as the tendency to depression are to be evaluated.

Brief summary in scientific language

In Germany, there are still no definitive guidelines for the evaluation of digital therapy procedures. The study design is therefore based on the recommendations of the National Institute for Health and Care Excellence in accordance with the "Evidence Standard Framework for Digital Health Technologies" of March 2019. According to this framework, the Kalmeda Tinnitus App can be classified in group 3a. Based on these recommendations, the evaluation design includes a combination of longitudinal and comparative group studies. There is an intervention group that starts treatment without any delay and a control group that starts the same treatment after a three-month waiting period. In the meantime, the waiting group receives information material about the tinnitus. The assignment of the patients to the intervention vs. control group is carried out by a computer-based randomisation procedure, which is assigned to an external provider in order to exclude influences.

Health condition or problem studied

ICD10:
H93.1 - Tinnitus
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
The intervention group uses the Kalmeda Tinnitus App immediately.
Arm 2:
The control group uses the Kalmeda tinnitus app after a 3 month waiting period and receives general information about tinnitus.

Endpoints

Primary outcome:
The primary outcome variable of the study is the total score of the tinnitus questionnaire by Göbel and Hiller. It is primarily used to assess the effectiveness of Kalmeda. The primary endpoint is defined as the tinnitus burden after three months.
Secondary outcome:
As secondary endpoints, the respective changes in tinnitus burden, depression tendency, stress experience and self-efficacy after 12 months (control group) or 9 months (intervention group) are selected.

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Other
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Doctor's practice Duisburg

Recruitment period and number of participants

Planned study start date:
2020-10-21
Actual study start date:
2020-08-07
Planned study completion date:
No Entry
Actual Study Completion Date:
2022-03-09
Target Sample Size:
150
Final Sample Size:
187

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Chronic tinnitus longer than 3 months

Exclusion Criteria

psychological diseases

Addresses

Primary Sponsor

Address:
mynoise GmbH
Christof Schifferings
Landshuterstraße 1
47249 Duisburg
Germany
Telephone:
01727985464
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kalmeda.de
Investigator Sponsored/Initiated Trial (IST/IIT):
No

Contact for Scientific Queries

Address:
HNO-Praxis
Dr.med. Roland Piers Uso Walter
Mülheimerstraße 70
47057 Duisburg
Germany
Telephone:
01788381852
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.hno-praxis-duisburg.de

Contact for Public Queries

Address:
HNO-Praxis
Dr. med. Roland Piers Uso Walter
Mülheimerstraße 70
47057 Duisburg
Germany
Telephone:
0203355310
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.hno-praxis-duisburg.de

Principal Investigator

Address:
HNO-Praxis
Dr.med. Roland Piers Uso Walter
Mülheimerstraße 70
47057 Duisburg
Germany
Telephone:
01788381852
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.hno-praxis-duisburg.de

Sources of Monetary or Material Support

Commercial (pharmaceutical industry, medical engineering industry, etc.)

Address:
mynoise GmbH
Landshuterstraße 1
47249 Duisburg
Germany
Telephone:
01727985464
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kalmeda.de

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Ärztekammer Nordrhein
Tersteegenstr. 9
40474 Düsseldorf
Germany
Telephone:
+49-211-43021581
Fax:
+49-211-43021585
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-01-24
Ethics committee number:
2020026
Vote of the Ethics Committee:
Approved
Date of the vote:
2020-05-20

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Prüfprotokoll
Zwischenergebnisse der Kalmeda Tinnitus-Studie
Abschlussbericht
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry